As dementia and other neurodegenerative diseases become more common worldwide, researchers are searching urgently for ways to ...

Collaborative Alzheimer’s care improved quality of life and saved billions when scaled nationwide, outperforming the antiamyloid drug lecanemab, results of a new cost analysis suggest.

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

Untreated sleep apnea can affect memory and other aspects of cognitive health, and it can get worse over time, with many ...